These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 10596737)

  • 1. Anabolic androgenic steroids and suicide.
    Thiblin I; Runeson B; Rajs J
    Ann Clin Psychiatry; 1999 Dec; 11(4):223-31. PubMed ID: 10596737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic-androgenic steroids and psychiatric-related effects: a review.
    Uzych L
    Can J Psychiatry; 1992 Feb; 37(1):23-8. PubMed ID: 1551042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anabolic androgenic steroids, antisocial personality traits, aggression and violence.
    Hauger LE; Havnes IA; Jørstad ML; Bjørnebekk A
    Drug Alcohol Depend; 2021 Apr; 221():108604. PubMed ID: 33621808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cause and manner of death among users of anabolic androgenic steroids.
    Thiblin I; Lindquist O; Rajs J
    J Forensic Sci; 2000 Jan; 45(1):16-23. PubMed ID: 10641914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Anabolic-Androgenic Steroid Use and Teen Dating Violence Among Adolescent Males.
    Ganson KT; Cadet TJ
    Subst Use Misuse; 2019; 54(5):779-786. PubMed ID: 30572768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse health effects of anabolic-androgenic steroids.
    van Amsterdam J; Opperhuizen A; Hartgens F
    Regul Toxicol Pharmacol; 2010 Jun; 57(1):117-23. PubMed ID: 20153798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
    Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
    Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men.
    Sharma A; Grant B; Islam H; Kapoor A; Pradeep A; Jayasena CN
    Best Pract Res Clin Endocrinol Metab; 2022 Sep; 36(5):101691. PubMed ID: 35999138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective treatment and prevention of attempted suicide, anxiety, and aggressiveness with fluoxetine, despite proven use of androgenic anabolic steroids.
    Amaral JMX; Padilha MC; Chagas SV; Baker JS; Mullen C; Vieira Neto L; Aquino Neto FR; Cruz MS
    Drug Test Anal; 2021 Jan; 13(1):197-202. PubMed ID: 32808487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between anabolic androgenic steroids and muscle dysmorphia: a review.
    Rohman L
    Eat Disord; 2009; 17(3):187-99. PubMed ID: 19391018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Central Effects of Androgenic-anabolic Steroid Use.
    Mędraś M; Brona A; Jóźków P
    J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
    Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
    Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
    Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
    Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric and medical effects of anabolic-androgenic steroid use in women.
    Gruber AJ; Pope HG
    Psychother Psychosom; 2000; 69(1):19-26. PubMed ID: 10601831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem?
    Kanayama G; Cohane GH; Weiss RD; Pope HG
    J Clin Psychiatry; 2003 Feb; 64(2):156-60. PubMed ID: 12633124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
    Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
    Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.
    Griffiths S; Jacka B; Degenhardt L; Murray SB; Larance B
    Drug Alcohol Rev; 2018 Jul; 37(5):664-670. PubMed ID: 29484740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic-androgenic steroids and the risk of imprisonment.
    Christoffersen T; Andersen JT; Dalhoff KP; Horwitz H
    Drug Alcohol Depend; 2019 Oct; 203():92-97. PubMed ID: 31421475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anabolic androgenic steroids and aggression: studies using animal models.
    McGinnis MY
    Ann N Y Acad Sci; 2004 Dec; 1036():399-415. PubMed ID: 15817752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control study.
    Kanayama G; Pope HG; Cohane G; Hudson JI
    Drug Alcohol Depend; 2003 Jul; 71(1):77-86. PubMed ID: 12821208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.